Suppr超能文献

急性心肌梗死再灌注治疗前中性粒细胞弹性蛋白酶活性的临床价值:与临床特征、再灌注事件及心肌损伤的比较

[Clinical value of PMN elastase activity before reperfusion therapy in acute myocardial infarction: comparison with clinical characteristics, reperfusion events and myocardial damage].

作者信息

Nishida Y, Matsuo H, Matsubara T, Ueno K, Kotoo Y, Oda H, Sugiyama A, Matsuno Y, Ohno M, Mori S

机构信息

Department of Cardiology, Gifu Prefectural Hospital.

出版信息

Kokyu To Junkan. 1992 Sep;40(9):917-22.

PMID:1439293
Abstract

Many recent studies demonstrate that neutrophils may be involved in the genesis and propagation of myocardial ischemia and reperfusion injury. Clinical value of PMN elastase activity before reperfusion which is released from activated polymorphonuclear leucocyte were evaluated in 30 patients with acute myocardial infarction. 19 patients with normal or moderately elevated PMN elastase activity (G1: less than 200 micrograms/l) revealed similar clinical characteristics before reperfusion therapy, compared to 11 patients with extremely high PMN elastase activity (Group 1: greater than or equal to 200 micrograms/l). But Group 1 represented fewer incidence of reperfusion events (Group 1 2/19, Group 2 7/11, p less than 0.01) such as arrhythmia, BP down, re-elevation of ST segments, and increased chest pain just after reperfusion, and higher incidence of salvaged myocardium in the risk area (Group 1 5/11, Group 2 4/19 p less than 0.1) evaluated by Tc-99m PYP, T1-201 dual SPECT, than Group 2. Wall motion analysis also showed that both global and regional wall motion were severely depressed in Group 2 compared with Group 1 (Group 1: Global EF 66.6 +/- 13.5, Extent 26.5 +/- 17.4, Severity 63.1 +/- 48.5, Group 2: Global EF 51.2 +/- 10.6, Extent 40.1 +/- 16.3, Severity 112.8 +/- 55.5, p less than 0.01 for Global EF, Extent, and p less than 0.05 for Severity). These data suggest that leucocyte activation before reperfusion may play important role in the genesis of reperfusion injury.

摘要

许多近期研究表明,中性粒细胞可能参与心肌缺血及再灌注损伤的发生和发展。对30例急性心肌梗死患者评估了再灌注前从活化多形核白细胞释放的PMN弹性蛋白酶活性的临床价值。19例PMN弹性蛋白酶活性正常或轻度升高(G1组:低于200微克/升)的患者在再灌注治疗前的临床特征与11例PMN弹性蛋白酶活性极高(G2组:大于或等于200微克/升)的患者相似。但G2组再灌注事件(如心律失常、血压下降、ST段再次抬高以及再灌注后胸痛加重)的发生率较低(G1组12/19,G2组7/11,p<0.01),而通过Tc-99m PYP、T1-201双SPECT评估,G2组危险区域存活心肌的发生率较高(G1组5/11,G2组4/19,p<0.1)。壁运动分析还显示,与G1组相比,G2组的整体和局部壁运动严重减弱(G1组:整体射血分数66.6±13.5,范围26.5±17.4,严重程度63.1±48.5;G2组:整体射血分数51.2±10.6,范围40.1±16.3,严重程度112.8±55.5,整体射血分数、范围p<0.01,严重程度p<0.05)。这些数据表明,再灌注前白细胞激活可能在再灌注损伤的发生中起重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验